Drugs / [Ga-68]MTP220
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07026981 | Sep 2025 → Jul 2026 overdue | head and neck cancer, malignant pancreatic neoplasm | Qiubai Li | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [Ga-68]MTP220 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07026981 ↗ |
| Modality | Diagnostic / imaging agent | “targeted PET tracer” NCT07026981 ↗ |
| Route | Intravenous | “by slow IV push” NCT07026981 ↗ |